Movement disorders at the National Institute of Neurology and Neurosurgery (INNN, Mexico City): most common diagnoses during 2022.
Objective: To provide data about the movement disorders (MD) outpatient consultation (OC) service from the INNN, Mexico City during 2022. Background: The INNN, inaugurated in…Improvement in spasticity-associated dressing- and hygiene-related disability in adults following treatment with incobotulinumtoxinA: a pooled analysis
Objective: To evaluate impact of incobotulinumtoxinA (incoA) on dressing- and hygiene-related disability (DRE and HYG) in adults with upper-limb spasticity (ULS) based on pooled data…Alterations of the Right Olfactory Orbitofrontal Cortex and olfactory impairment in Parkinson’s Disease
Objective: To explore the potential role of the right olfactory orbitofrontal cortex in olfactory dysfunction (OD) in Parkinson’s Disease (PD). Background: The orbitofrontal cortex (OFC)…Correlation between dose of dopamine replacement therapy and King’s Parkinson’s Disease Pain Scale in Mexican Patients with Parkinson’s Disease
Objective: Investigate the relationship between the dose of dopamine replacement therapy (DRT) and pain severity as measured by the King's Parkinson's Disease Pain Scale (KPPS)…Clinical toolkits to improve conversations about Parkinson’s dementia
Objective: To co-produce, with people living with Parkinson’s and professionals, a pair of toolkits to improve conversations about Parkinson’s dementia in the clinic: one for…Association between dysphagia and body mass index and his impact on the severity of anxiety in patients with Parkinson Disease
Objective: To describe the relation between dysphagia and body mass index and the increase in anxiety and depression in patients with parkinson’s disease. Background: Parkinson’s…Why Me Why Not? Understanding the Perception of Research among African Americans with PD
Objective: To recognize the barriers of participating in PD research with qualitative and quantitative data. Background: Women, minorities, and people over 70 years of age…Movement-related modulation of beta/high frequency oscillations and low-beta pallido-cortical coherence in Parkinson’s disease.
Objective: To characterize changes in synchronized oscillatory activity and coherence between the globus pallidus (GPi) and primary motor cortex (M1) of Parkinson’s disease (PD) patients…Clinical characterization of patients with functional movement disorders
Objective: To clinically characterize functional movement disorders in a Cuban cohort. Background: Functional movement disorders are those that cannot be explained by an organic disease…Improvements in Parkinson’s disease motor complications after treatment with opicapone: results from the OPTI-ON study
Objective: To describe motor complications as measured by the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) Part IV in participants from the Opicapone Treatment…
- « Previous Page
- 1
- …
- 533
- 534
- 535
- 536
- 537
- …
- 1734
- Next Page »